Budget Impact Models
RXA Budget Impact Model
With the RXA Budget Impact model you can:
- Create summary overviews at annual and portfolio levels
- Drill down to underlying detailed product-specific calculations
- Use tables, charts and maps in the purpose-built dashboard to provide extensive, highly visual and easy to interpret analytics
- Make on the spot adjustments of model parameters – (E.g. switch %) via slider controls
- Automatically rank the top ‘X’ GP practices to target
- Create outputs to leave behind after meetings – Including CCG or GP practice level branded reports containing details of identified cost savings
Request your demonstration today
Andrew Norman, Director
Rx Analyser is already having a significant impact on our business, allowing our Territory Managers to focus on established CCG accounts and identify practice level successes and others for further development.
Managing Director, UK Diabetes Healthcare Company
The budget impact models are a real benefit.
National Sales Manager, UK Pharmaceutical Company
Our sales team use RX Analyser to analyse results and opportunity; it’s used by management to measure performance and identify national trends to drive targeting and strategy.
National Sales Manager, UK Pharmaceutical Company
Obviously I wouldn’t recommend Rx Analyser to our direct competitors as I believe the level of insight provided really gives us an edge.
Sales and Marketing Manager, Leading Healthcare Company, 2016
Working with Inspiremed is a great partnership experience and they make sure they understand your business, the industry that you are in and what you want to achieve in the use of the product.
National Sales Manager, UK Pharmaceutical Company
We chose Rx Analyser is because we wanted visibility of sales for our products. Rx Analyser is perfect for delivering a detailed level of data to practice level. The data is enabling us to set targets at territory level and assist our planning process as we can understand our competitor sales via Rx Analyser far better than previously.